DGX. Focus Diagnostics and 3M Launch FDA-Cleared Simplexa™ Test on 3M™ Cycler for Molecular Influenza and Respiratory Virus Testing by Moderate Complexity Healthcare Facilities First moderate-complexity Simplexa™ assay developed through funding by U.S. Department of Health and Human Services' BARDA BAA program for public health preparedness http://finance.yahoo.com/news/focus-diagnostics-3m-launch-fda-162700013.html